Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | AilseVax |
Description | Immuno-oncology Ailsevaxis based on the 3 core elements: neo-antigens discovery, cancer vaccine development, effective adjuvants and delivery platforms. AilseVax are developing innovations across all three domains to develop the next generation of cancer vaccine |
Keywords | N/A |
WebSite | ailsevax.com |
Host IP | 75.2.70.75 |
Location | United States |
Site | Rank |
US$1,592
Last updated: 2023-05-18 12:47:28
ailsevax.com has Semrush global rank of 0. ailsevax.com has an estimated worth of US$ 1,592, based on its estimated Ads revenue. ailsevax.com receives approximately 183 unique visitors each day. Its web server is located in United States, with IP address 75.2.70.75. According to SiteAdvisor, ailsevax.com is safe to visit. |
Purchase/Sale Value | US$1,592 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$44 |
Yearly Ads Revenue | US$529 |
Daily Unique Visitors | 12 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ailsevax.com. | A | 600 | IP: 75.2.70.75 |
ailsevax.com. | A | 600 | IP: 99.83.190.102 |
ailsevax.com. | NS | 3600 | NS Record: ns47.domaincontrol.com. |
ailsevax.com. | NS | 3600 | NS Record: ns48.domaincontrol.com. |
ailsevax.com. | MX | 3600 | MX Record: 1 mail.ailsevax.com. |
ailsevax.com. | TXT | 3600 | TXT Record: zone-ownership-verification-1c456c53151c6b7e6da4a06919f61e8be52e480948a391e21cc02d5893a37f10 |
Home Our Company Our Pipeline News News + Press Releases Contact Immuno-oncology vaccines Discovery | Development | Delivery Our Company AilseVax is developing the next generation of cancer vaccines by focusing on three core elements of cancer vaccine development: Novel adjuvants Neoantigen discovery Innovative delivery platforms Founded by experts in cancer biology, immunology and data science, with an experienced management team with an excellent track-record in building multiple successful life sciences ventures. Founders & Advisors Prof. Ed Lavelle TCD, Founder Immunology & adjuvant expert Past president of Irish Society for Immunology Prof. Chris Scott QUB, Founder Dean of Research, Medicine, Health & Life Sciences Ex-Fusion Antibodies MRC DPFS Panel Dr. Simon McDade QUB, Founder Functional Genomics expert Lead QUB Genomics Core Prof. Dan Longley QUB, Founder Director, Patrick G. Johnston Centre for Cancer Research Innovate UK Scholar, Almac Discovery Led recent partnering drug |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Sat, 18 Jun 2022 09:14:01 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://ailsevax.com/ HTTP/2 301 server: openresty date: Sat, 18 Jun 2022 09:14:01 GMT content-type: text/html content-length: 166 location: https://www.ailsevax.com/ HTTP/2 200 server: openresty date: Sat, 18 Jun 2022 09:14:02 GMT content-type: text/html content-length: 24917 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 0 x-served-by: cache-iad-kjyo7100177-IAD, cache-dub4332-DUB x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1655543642.783240,VS0,VE222 vary: x-wf-forwarded-proto, Accept-Encoding x-cluster-name: eu-west-1-prod-eks-15 |
Domain Name: AILSEVAX.COM Registry Domain ID: 2625157526_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-07T22:36:59Z Creation Date: 2021-07-07T22:36:59Z Registry Expiry Date: 2022-07-07T22:36:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS47.DOMAINCONTROL.COM Name Server: NS48.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-06-18T09:22:04Z <<< |